CPU-0213

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCPU-0213
Drug Alias Namedajisentandual ETA/ETB receptor antagonist (China Pharmaceutical University)CPU-0213
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor type A antagonistsEndothelin receptor type B antagonists
TargetsEndothelin receptor type AEndothelin receptor type B
Therapy Area/IndicationsCardiovascular DiseasesRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesChina Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChina Pharmaceutical University
Active IndicationsN/A
Inactive IndicationsCardiovascular DiseasesRenal Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A